The Effect and Safety of Anti-PD-1 Single/Combination Therapy in Refractory Thymic Carcinoma: A Case-Series Study

Wei Jin,1,* Jian-Chun Duan,2,* Zhi-Jie Wang,2 Lin Lin,2 Hua Bai,2 Jie Wang,2 Li Feng1 1Department of Chinese Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, People&...

Full description

Bibliographic Details
Main Authors: Jin W, Duan JC, Wang ZJ, Lin L, Bai H, Wang J, Feng L
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/the-effect-and-safety-of-anti-pd-1-singlecombination-therapy-in-refrac-peer-reviewed-article-CMAR